Jakavi is an anticancer drug distributed to the group of protein kinase blockers. As a rule, this remedy is used exclusively to eliminate myelofibrosis, and the primary or secondary forms of the disease can be cured. The main active ingredient of the drug is the so-called substance ruxolitinib. Jakavi 5mg (Ruxolitinib) - Jakavi (Ruxolitinib) - how does the drug work? According to its pharmacological action, Jakavi is a selective inhibitor of a special group of enzymes called JAK kinase. It is these substances that are directly involved in the work of the immune system, as well as in the stimulation of hematopoiesis. With the development of myelofibrosis, the work of JAK kinases leaves the usual state, which stimulates the development and appearance of a large number of malignant cells. The drug Jakavi blocks the pathogenic effect of kinases, thereby significantly reducing the number of tumor cells and stopping the process of their development. You can find out what is the price for Jakavi 5mg (Ruxolitinib) - Jakavi (Ruxolitinib) by contacting the manager of our online pharmacy.
Application scheme Jakavi is taken exclusively by mouth. The drug is normally absorbed regardless of whether there is food in the stomach or not. At the initial stage of therapy, the dosage of the drug is calculated depending on the volume and number of platelet cells in the blood. If the volume of platelet cells is no more than 100x109 in one liter, 5 mg of the active substance will be prescribed twice in 24 hours. With the number of platelet units from 100 to 200 multiplied by 109 in one liter, the patient will be prescribed 15 mg of Jakavi twice a day. If there are more than 200x109 platelet cells in one liter of blood, the calculation of the use of the drug is 20 mg twice a day. Treatment with this medication should be continued until the patient has a positive effect. You can read about the drugJakavi 5mg (Ruxolitinib) - Jakavi (Ruxolitinib) reviews on forums - as a rule, they are positive. How effective is Jakavi? The effectiveness of the drug can be assessed by clinical studies. According to the results obtained, the majority of patients showed an improvement in hematocrit. Moreover, half of all patients taking part in the experiment noted a decrease in the intensity of manifestation of symptoms of the disease. If you are interested in the cost for Jakavi 5mg (Ruxolitinib) - Jakavi (Ruxolitinib) - the current price can be checked with the employee of our online pharmacy.
©2020 CopyRight Onco24.com. All rights reserved.